🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1, randomized, open-label, 2-way crossover, pharmacokinetic...
Status
Unknown
Location
Multiple Locations
Start Date
2020-08-15
Trial ID
NCT04243434
Treatments Being Tested
To evaluate the efficacy of celecoxib combined with R-CHOP versus R-CHOP in...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-03-06
Trial ID
NCT07494565
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of orelabr...
Status
Unknown
Location
The first affiliated hospital of bengbu medical college
Start Date
2022-11-02
Trial ID
NCT05234684
Treatments Being Tested
This phase II/III trial tests whether it is possible to decrease the chance...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-10-22
Trial ID
NCT03984448
Phase 3 randomized, double-blind, placebo-controlled, study assessing the e...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-10-08
Trial ID
NCT04529772
Treatments Being Tested
This study will evaluate the ability of a largely self-administered geriatr...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge
Start Date
2013-04
Trial ID
NCT01829958
Treatments Being Tested
This observational study evaluates the predictive value of systemic inflamm...
Status
Recruiting
Location
Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Ain Shams University
Start Date
2025-05-05
Trial ID
NCT07057765
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Completed
Location
University Hospital Brno
Start Date
2004-02
Trial ID
NCT00290667
A multicenter, prospective, randomized, open-label, controlled trial to eva...
Status
Unknown
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2022-06-01
Trial ID
NCT05351346
Treatments Being Tested
To evaluate the feasibility of adding induction and maintenance Avelumab to...
Status
Unknown
Location
Ballarat Health
Start Date
2017-07-21
Trial ID
NCT03244176
Treatments Being Tested